GMP Milrinone Injection 5mg/5ml 10mg/10ml Ampoule Phosphodiesterase Inhibitor

• Customization: Available
• Application: Injection
• Usage Mode: IV
• Model NO.: 5mg/5ml 10mg/10ml
• Suitable for: Adult
• State: Liquid
• Shape: Liquid
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Molecular Formula: C12h9n3o
• Molecular Weight: 211.22
• Character: Colorless Clear Liquid
• Supplementary Materials: Sodium Chloride
• Transport Package: 5 Ampoules /Tray/Box
• Specification: 5mg/5ml 10mg/10ml
• Trademark: Without
• Origin: China
• HS Code: 3004909099
• Production Capacity: 10000000 Ampoules Per Month

Product Description

Product Description

 

Milrinone injection

It  is used for the treatment of acute and chronic refractory congestive heart failure caused by various reasons, such as digitalis, diuretics, vasodilators, which are ineffective or ineffective.

Indication

It is suitable for the treatment of acute and chronic refractory congestive heart failure caused by various reasons, such as digitalis, diuretics and vasodilators.

Usage and dosage

Intravenous injection: load 25-75 μ g / kg, 5-10 minutes of slow intravenous injection, after every minute 0.25-1.0 μ g / kg maintenance.
The maximum daily dose shall not exceed 1.13mg/kg.

Oral: 2.5-7.5mg once, 4 times a day.

  Adverse reaction

It is less than amrinone. A few have headache, ventricular arrhythmia, weakness, thrombocytopenia and so on.
When overdose, there may be hypotension and tachycardia.
Long term oral administration is no longer used because of its side effects, which can lead to a long-term increase in mortality.